Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05916781
What this trial is testing

Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Chinese SLE Treatment And Research Group 220
Not applicableLooking for participantsNCT06527872
What this trial is testing

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

Who this might be right for
Lupus Nephritis
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05517980
What this trial is testing

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

Who this might be right for
Glomerulonephritis
Kira Pharmacenticals (US), LLC. 52
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Not applicableUnknownNCT01126931
What this trial is testing

Wormwood in Chronic Progressive Disorders With Reduced Appetite

Who this might be right for
Cancer
University Hospital Freiburg 300
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableLooking for participantsNCT07666711
What this trial is testing

Biomarker Development for Autoimmune Disorders Involving the Kidneys

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Oslo University Hospital 500
Testing effectiveness (Phase 2)WithdrawnNCT04883619
What this trial is testing

Nipocalimab in Adult Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC
Not applicableStudy completedNCT06767592
What this trial is testing

Probiotics in IgA Nephropathy

Who this might be right for
IgA Nephropathy
University of Leicester 18
Post-approval studies (Phase 4)Not Yet RecruitingNCT07035834
What this trial is testing

SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis

Who this might be right for
Lupus Nephritis (LN)ANCA Associated Vasculitis (AAV)
Federico II University 40
Testing effectiveness (Phase 2)Study completedNCT03200002
What this trial is testing

Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis

Who this might be right for
To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients
Chitwan Medical College 49
Not applicableUnknownNCT05845762
What this trial is testing

Obinutuzumab in the Management of Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 30
Early research (Phase 1)Study completedNCT06064929
What this trial is testing

Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Who this might be right for
Lupus Nephritis
HI-Bio, A Biogen Company 14
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Not applicableStudy completedNCT00342329
What this trial is testing

Lupus Nephritis: Role of Environmental and Occupational Exposures

Who this might be right for
Lupus Nephritis
National Institute of Environmental Health Sciences (NIEHS)
Post-approval studies (Phase 4)UnknownNCT04020328
What this trial is testing

Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

Who this might be right for
Glomerulonephritis, IGARenal Insufficiency, Chronic
Shenzhen Second People's Hospital 70
Large-scale testing (Phase 3)Looking for participantsNCT06994845
What this trial is testing

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Who this might be right for
Primary Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Study completedNCT00429377
What this trial is testing

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

Who this might be right for
Lupus Nephritis
Astellas Pharma Inc 64
Testing effectiveness (Phase 2)Ended earlyNCT03459443
What this trial is testing

A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471

Who this might be right for
C3 GlomerulonephritisC3 GlomerulopathyImmune Complex Membranoproliferative Glomerulonephritis+2 more
Alexion Pharmaceuticals, Inc. 22
Next Page